JSPR Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Jasper Therapeutics Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 23.21 USD -2.56%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast JSPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JSPR is 68.85 USD with a low forecast of 55.55 USD and a high forecast of 84 USD.

JSPR Lowest Forecast

Wall Street Target

JSPR Average Forecast

Wall Street Target

JSPR Highest Forecast

Wall Street Target

139% Upside

197% Upside

262% Upside

The latest public price target was made on Apr 3, 2024 by Gavin Clark-Gartner from Evercore ISI , who expects JSPR stock to rise by 180% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Gavin Clark-Gartner Evercore ISI	65 USD Upside 180%	2 weeks ago Apr 3, 2024	Evercore ISI Starts Jasper Therapeutics (JSPR) at Outperform StreetInsider
Unknown Analyst Cantor Fitzgerald	6 USD Downside 74%	1 year ago Feb 7, 2023	Cantor Fitzgerald Reiterates Overweight on Jasper Therapeutics, Lowers Price Target to $6 Benzinga

Price Target	65 USD
Upside/Downside	180%

Price Target	6 USD
Upside/Downside	74%

Japan Tissue Engineering Co Ltd

79% Upside

Acticor Biotech SA

183% Upside

ReproCell Inc

90% Upside

Neurogene Inc

60% Upside

Japan Tissue Engineering Co Ltd

79% Upside

Acticor Biotech SA

183% Upside

ReproCell Inc

90% Upside

Neurogene Inc

60% Upside

Genmab A/S

39% Upside

Acumen Pharmaceuticals Inc

313% Upside

Orthocell Ltd

54% Upside

Alvotech SA

31% Upside

Revenue
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-2%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-77%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for JSPR is 68.85 USD with a low forecast of 55.55 USD and a high forecast of 84 USD.

Join more than 129,000+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.